XWELL reports FY 2024 revenue $33.9M (+13% YoY), net loss narrows to $16.9M

XWELL, Inc.

2025-Q1 EPS reported -$1.00 revenue$7,023,000

Revenue $33.9M (+13% YoY); gross margin rose to 26.3% from 12.2%.
Net loss attributable to XWELL narrowed to $16.9M from $27.7M in 2023.
CDC extended Traveler-based Genomic Surveillance Program for 3 years; base value $53.7M, ceiling $85.7M.
Closed $4M private placement in Jan 2025; plans to acquire medical spas in select metros in 2025.
Cash & equivalents $4.6M, marketable securities $7.3M, no long-term debt.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-035179
form_type: 8-K
ticker: XWEL
cik: 0001410428
company_name: XWELL, Inc.
filed_at: 2025-04-15T23:59:59+00:00
discovered_at: 2026-05-14T18:02:48.201530+00:00
generated_at: 2026-05-23T14:25:32.212288+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-035179
json_url: https://secwatch.observer/filing/0001104659-25-035179.json
markdown_url: https://secwatch.observer/filing/0001104659-25-035179.md
text_url: https://secwatch.observer/filing/0001104659-25-035179.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1410428/000110465925035179/0001104659-25-035179-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1410428/000110465925035179/tm2512312d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-035179

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.